Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Distinct parafacial regions in control of breathing in adult rats

  • Robert T. R. Huckstepp,

    Roles Conceptualization, Data curation, Formal analysis, Methodology, Writing – original draft, Writing – review & editing

    Current address: School of Life Sciences, University of Warwick, Coventry, United Kingdom.

    Affiliation Department of Neurobiology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

  • Kathryn P. Cardoza,

    Roles Data curation, Writing – review & editing

    Affiliation Department of Neurobiology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

  • Lauren E. Henderson,

    Roles Data curation, Writing – review & editing

    Affiliation Department of Neurobiology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

  • Jack L. Feldman

    Roles Conceptualization, Funding acquisition, Methodology, Writing – original draft, Writing – review & editing

    feldman@g.ucla.edu

    Affiliation Department of Neurobiology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America

Abstract

Recently, based on functional differences, we subdivided neurons juxtaposed to the facial nucleus into two distinct populations, the parafacial ventral and lateral regions, i.e., pFV and pFL. Little is known about the composition of these regions, i.e., are they homogenous or heterogeneous populations? Here, we manipulated their excitability in spontaneously breathing vagotomized urethane anesthetized adult rats to further characterize their role in breathing. In the pFL, disinhibition or excitation decreased breathing frequency (f) with a concomitant increase of tidal volume (VT), and induced active expiration; in contrast, reducing excitation had no effect. This result is congruent with pFL neurons constituting a conditional expiratory oscillator comprised of a functionally homogeneous set of excitatory neurons that are tonically suppressed at rest. In the pFV, disinhibition increased f with a presumptive reflexive decrease in VT; excitation increased f, VT and sigh rate; reducing excitation decreased VT with a presumptive reflexive increase in f. Therefore, the pFV, has multiple functional roles that require further parcellation. Interestingly, while hyperpolarization of the pFV reduces ongoing expiratory activity, no perturbation of pFV excitability induced active expiration. Thus, while the pFV can affect ongoing expiratory activity, presumably generated by the pFL, it does not appear capable of directly inducing active expiration. We conclude that the pFL contains neurons that can initiate, modulate, and sustain active expiration, whereas the pFV contains subpopulations of neurons that differentially affect various aspects of breathing pattern, including but not limited to modulation of ongoing expiratory activity.

Introduction

Several brainstem motor nuclei are surrounded by respiratory-related neurons [1, 2]. In the case of the facial nucleus, parafacial neurons are essential components of the breathing central pattern generator (bCPG). In particular, parafacial neurons that express the neurokinin-1 receptor (NK1R), the homeobox gene Phox2b, and the glutamate transporter VGlut2, are essential to CO2 chemoreception [36]; notably, a subpopulation of these neurons have rhythmic respiratory-related activity, both in vitro and in vivo [79], leading us to postulate that breathing is driven by a dual oscillator system [10]. We identified two neighboring parafacial regions, lateral (pFL) and ventral (pFV) that appear to be functionally distinct components of the bCPG [11]. We hypothesized that the pFL is a conditional expiratory oscillator that is inhibited at rest [8, 11, 12], whereas the pFV provides a generic source of excitatory drive for both inspiration and expiration whose activity depends, at least in part, on CO2-related signals [11, 1315]. Furthermore, two parafacial subpopulations, containing Gastrin-Releasing Peptide and Neuromedin B (GRP and NMB, respectively) modulate sighing [16]. Therefore, further subdivision of the parafacial region into functionally distinct nuclei may be warranted, as is the case for other subcortical brain regions, such as the nucleus tractus solitarius, periaqueductal gray, and paraventricular nucleus [1719]. To further investigate the functional contributions of the pFL and pFV, we selectively modulated their excitability and measured the effects on ventilation in spontaneously breathing vagotomized urethane anesthetized adult rats.

We conclude that the: i) pFL contains a functionally homogenous population of excitatory neurons that are tonically inhibited at rest, which following an increase in excitability can initiate and maintain active expiration; ii) pFV contains at least four functionally distinct subpopulations of neurons: three subpopulations that are tonically inhibited at rest, which can separately affect f, modulate active expiration, and modulate basal sigh rate, and one tonically active subpopulation that predominately affects VT. Interestingly no subpopulation of pFV neurons appears capable of directly inducing active expiration; instead the pFV modulates active expiration generated elsewhere, presumably by effects in the pFL and/or (pre)motoneuron pools.

Methods

All protocols were approved by the University of California Los Angeles Chancellor’s Animal Research Committee. All experiments were performed in spontaneously breathing vagotomized urethane anesthetized adult Male Sprague-Dawley rats (350–450 g) rats.

Ventral approach

Anesthesia was induced with isofluorane and maintained with urethane (1.2–1.7 g/kg; Sigma) in sterile saline via a femoral catheter. Rats were placed supine in a stereotaxic apparatus on a heating pad to maintain body temperature at 37±0.5°C. The trachea was cannulated. Respiratory flow was monitored via a flow head (GM Instruments), and CO2 via a capnograph (Type 340: Harvard Apparatus) connected to the tracheal tube. Paired electromyographic (EMG) wires (Cooner Wire Co.) were inserted into genioglossal (GG), diaphragmatic (Dia), and oblique abdominal muscles (Abd). Anterior neck muscles were removed, a basiooccipital craniotomy exposed the ventral medullary surface, and the dura was resected. After bilateral vagotomy, exposed tissue around the neck and mylohyoid muscle were covered with dental putty (Reprosil; Dentsply Caulk) to prevent drying. Rats were left for 30 minutes for breathing to stabilize. At rest, ventilation consisted of alternating active inspiration and passive expiration. Once stabilized, solutions of drugs in micropipettes were pressure injected (100–200 nL) bilaterally using a Picospritzer II (General Valve Corp.) controlled by a Master 8 pulse generator (AMPI) into the pFL or pFV (Fig 1). To reduce disruption of the tissue, solutions were injected at ~50 nL/min. To ensure parity of injections of different drugs, i.e., AMPA, B+S, A+N, and consistency between both sites, i.e., pFL and pFV, the bilateral injections of a drug were performed ~2 mins apart. The timing between; the 2 injections of AMPA (119 ± 16 sec), the 2 injections of B+S (121 ± 10 secs), and the 2 injections of A+N (121 ± 15 secs) were not statistically different (F[2, 47] = 0.01; p = 0.98; 2-way ANOVA), and no differences were found between the timings of the 2 injections in the pFV (121 ± 8 secs) and the 2 injections in the pFL (120 ± 13 secs; F[1,47] = 0.0004; p = 0.98; 2-way ANOVA). The timing between the 2 injections of Glu before (122 ± 13 secs) and after (120 ± 13 secs) vagotomy, were also not statistically different (p = 0.8; paired T-test). After each injection rats were allowed 30–45 minutes for drugs to take effect and washout, and for baseline recordings to stabilize before the next injection.

thumbnail
Fig 1. Histological analysis of parafacial regions.

A) Localization of injections into pFV and pFL. Transverse view of medulla at Bregma -11.25 mm. Red circles show locations of injection sites for pFV and pFL. Green dashed box is magnified in C. B) Ventral view of medullary surface with location of pFV and pFL injection sites, marked by white circles, superimposed. C) Micrographs of injection sites. Green marks staining for choline acetyl transferase (ChAT), highlighting the cholinergic neurons of the facial (VII) nucleus, and red marks fluorescent beads coinjected with micropipette solutions in to the pFV and pFL. Py–Pyramidal tract, SP-5 –Spinal trigeminal tract, 7n –Facial nucleus.

https://doi.org/10.1371/journal.pone.0201485.g001

The pFL is defined as the area ventral to the lateral edge of the facial nucleus, juxtaposed to the spinal trigeminal tract [11]. The pFV is defined as the area ventral to the caudal half of the facial nucleus, at a central location between the pyramidal tract and the spinal trigeminal tract [11]. Coordinates: lateral from the basilar artery, rostral from the rostral hypoglossal nerve rootlet, and dorsal from the ventral surface (in mm); pFV: 1.8, 0.6, 0.1, and pFL: 2.5, 0.9, 0.2.

Injections contained: i) bicuculline methylbromide (250 μM; Tocris) and strychnine hydrochloride (250 μM; Sigma) (B+S) to antagonize GABAA and glycine receptors, respectively. Injections of B+S led to disinhibition of the pFL (B+SpFL) or pFV (B+SpFV); ii) AMPA (20 μM; Sigma) to activate glutamatergic AMPA receptors. Injections of AMPA lead to excitation of the pFL (AMPApFL) or pFV (AMPApFV) or; iii) 2-amino-5-phosphopentanoic acid (AP-5; 1mM; Sigma) and 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione (NBQX; 1mM; Sigma) (A+N) to antagonize glutamatergic NMDA and AMPA receptors, respectively. Injections of A+N reduced excitation in the pFL (A+NpFL) or pFV (A+NpFV). All drugs were diluted in sterile saline balanced with NaOH to pH 7.35.

In one set of experiments, a ventral approach to the medulla was performed in vagus-intact rats. After a resting period to allow breathing to stabilize, rats received 100–200 nL bilateral injections of glutamate (10 mM; Sigma) administered at ~50 nL/min into the pFV (GlupFV), following which breathing was allowed to recover. After breathing returned to baseline levels, rats were bilaterally vagotomized at the mid-cervical level. Breathing was allowed to stabilize (~30–60 mins), following which rats received a second bilateral injection of GlupFV.

Care was taken to reduce any transient effects of mechanical stimulation when placing the pipette into the tissue. As experimental controls to determine whether insertion of the pipette and injection of solution per se had effects, we tested the effects of saline injections.

All injections contained fluorescent beads (red fluoSpheres; Invitrogen) to allow for post-hoc identification of injection sites.

Localization of injection sites (Fig 1)

Rats were sacrificed by overdose of urethane and transcardially perfused with saline followed by cold (4°C) paraformaldehyde (PFA; 4%). The medulla was harvested and postfixed in 4% PFA overnight at 4°C, then cryoprotected in sucrose (30%) in standard PBS (1–3 days at 4°C). PBS contained (mM): NaCl 137, KCl 2.7, Na2HPO4 10, KH2PO4 1.8, pH 7.4. Brainstems were transversely sectioned at 40 μm. Free-floating sections were incubated overnight in PBS containing 0.1% Triton X-100 (PBT) and mouse anti-NeuN primary antibody (1:500; EMD Millipore) or goat anti-cholineacetyl transferase (ChAT; 1:100; EMD Millipore). The tissue was washed in PBS, 6 times for 5 minutes per wash, and then incubated separately for 2–4 hours in a solution of PBT containing either donkey anti-mouse Alexa Fluor 647 secondary antibody (1:250; Jackson ImmunoResearch Laboratories, Inc.) or donkey anti-goat Alexa Fluor 488 (1:250; Invitrogen), for NeuN and ChAT, respectively. The tissue was washed in PBS, 6 times for 5 minutes. Slices were mounted onto polylysine-coated slides, dehydrated overnight at 22°C, and coverslipped using Cytoseal 60 (Electron Microscopy Sciences). Slides were analyzed using a fluorescent microscope with AxioVision acquisition software (AxioCam2, Zeiss).

Data analysis and statistics

EMG signals and airflow measurements were collected using preamplifiers (P5; Grass Instruments) connected to a Powerlab AD board (ADInstruments) in a computer running LabChart software (ADInstruments), and were sampled at 400 Hz/channel. High pass filtered (>0.1 Hz) flow head measurements were used to calculate: tidal volume (VT, peak amplitude of the integrated airflow signal during inspiration; pressure sensors were calibrated with a 3 mL syringe); VT is expressed as mL. Inspiratory duration (TI, beginning of inspiration until peak VT), expiratory duration (TE, peak VT to the beginning of the next inspiration), and f (1/[TI+TE]); TI and TE, are expressed in secs (s), and f is expressed as breaths per minute (BPM). Minute ventilation (Ve) was calculated as f x VT, and is expressed as mL/min. EMG data were integrated (τ = 0.05 s; ∫DiaEMG, ∫GGEMG, and ∫AbdEMG in arbitrary units (a.u.)) and the peak amplitude of each signal computed for each cycle.

To obtain control values, all parameters were averaged for 20 respiratory cycles preceding each injection. To measure drug effect, 20 cycles were averaged during a period where the injection had its greatest effect on the airflow channel. Measurements were only made of the initial response to the drug, usually within the first 5 minutes following the 2nd injection, at a similar time as the expanded traces in the figures (marked in each figure by a black arrow with a black dotted line). Care was taken to avoid measurements where reflexive changes had taken place, for example, where the drug caused an initial decrease in breathing followed by a compensatory increase in breathing as the compound wore off. In these cases, measurements were taken at the peak effect during initial decrease and not during the reflexive increase that followed. Data was analyzed offline and exported to Excel™ (Microsoft) for further analysis. All statistical tests were performed using Igor Pro™ (WaveMetrics), except 2-way ANOVAs which were performed in OriginPro™ (OriginLab).

As described above, for each rat we calculated the average of 20 cycles preceding the stimulus (control), and the average of 20 cycles during the stimulus (stimulus). Both groups, the control values and their associated stimulus value for every rat, were combined into a single data set. To facilitate graphical comparisons data was normalized to the highest value in the data set regardless of whether it belonged to control or stimulus group. Therefore, the highest value in the data set, whether it be control or stimulus, was 1.0.

We define active expiration as the epoch of appearance of burst activity in expiratory muscles, i.e., abdominals, that leads to forced air outflow, typically during late expiration, and consequently, increased VT in the following inspiration. We define sighs by their characteristic augmented VT caused by a second inspiratory effort that occurs before the initial eupneic inspiration is complete. These augmented breaths result from largely from high amplitude inspiratory DiaEMG.

Data were not normally distributed. Data were therefore analyzed using the non-parametric 2-sided Wilcoxon signed-rank test with a significance level of P ≤ 0.05 and reported as median and interquartile range (IQR). Data are displayed as box and whisker plots for comparison of groups, and as line graphs for individual experiments. There were 8 biological repeats and no technical repeats in all data sets, with 2 exceptions: Statistical outliers were excluded from the data if they failed both Pierce’s criterion and Grubb’s test; this led to the removal of 1 outlier from the AbdEMG data from the AMPApFV and AMPApFL data sets.

Power analysis was calculated in G*Power3 (http://www.gpower.hhu.de/en.html [20]), using a Wilcoxon signed rank tests (matched pairs): with an α error probability of 0.05, and a power (1-β error probability) of 0.90, and effect sizes were calculated from the data (Table 1).

Results

Disinhibition of pFL or pFV affect breathing pattern (Figs 25, Table 2)

Disinhibition of pFL neurons by the GABAergic antagonist bicuculline and the glycine antagonist strychnine (B+SpFL) can induce active expiration [8, 11], which we confirm here. Bilateral injection of B+SpFL (n = 8) decreased f and TI, increased TE, VT, ∫DiaEMG, and inspiratory-related ∫GGEMG activity, and induced rhythmic expiratory bursting in ∫GGEMG and ∫AbdEMG (Fig 2), the latter a signature of active expiration, q.v., [8, 11]. Bilateral B+SpFL had no effect on minute ventilation (Ve) due to a compensatory increase in VT in response to the changes in f elicited by the antagonism of the inhibitory receptors.

thumbnail
Fig 2. B+SpFL induces active expiration.

A) Integrated traces from a single experiment. Black arrows at bottom indicate epochs in expanded traces (Bi and Bii), gray arrows at top indicate unilateral injections for B+SpFL. Bi) Rest. Bii) Following B+SpFL. Grey vertical boxes demark period of each breath taken up by inspiration (I; light gray), post-inspiration (Post: medium grey), and pre-inspiration (Pre: Dark gray). C) Comparison between ventilation at rest (Rst) and after B+SpFL injection. Lines connect data from individual experiments, box and whisker plots show combined data. Data are normalized to highest value for each parameter, i.e., f, TI, TE, VT, GGEMG, DiaEMG, or AbdEMG regardless of whether it belonged to control or B+SpFL group. *: p < 0.05. frequency–f, TI−inspiratory period TE,–expiratory period, tidal volume–VT, GGEMG−genioglossus electromyogram, DiaEMG−diaphragm electromyogram, AbdEMG−abdominal electromyogram. BPM–breaths per minute, a.u.—arbitrary units.

https://doi.org/10.1371/journal.pone.0201485.g002

thumbnail
Fig 3. B+SpFV increases f, decreases VT, and induces post-inspiratory activity in abdominal muscles and pre- and post-inspiratory activity in gengioglossus muscles.

A) Integrated traces from a single experiment. Black arrows at bottom indicate epochs in expanded traces (Bi and Bii), gray arrows at top indicate unilateral injections for B+SpFV. Examples of sighs are marked with arrowheads labelled with #. Post-inspiratory burst AbdEMGs are marked with arrowheads labelled with †. Bi) Rest. Bii) Following B+SpFV. Grey vertical boxes demark phases of each breath: inspiration (I; light gray), post-inspiration (Post: medium grey), and pre-inspiration (Pre: Dark gray). Sigh marked by #. Post-Inspiratory AbdEMG marked by †. C) Comparison between ventilation at rest (Rst) and after B+SpFV injection. Lines connect data from individual experiments, box and whisker plots show combined data. Data are normalized to highest value for each parameter, i.e., f, TI, TE, VT, GGEMG, DiaEMG, or AbdEMG regardless of whether it belonged to control or B+SpFL group. *: p < 0.05. Abbreviations defined in Fig 2.

https://doi.org/10.1371/journal.pone.0201485.g003

thumbnail
Fig 4. SalinepFL does not affect breathing.

A) Integrated traces from a single experiment. Black arrows at bottom indicate epochs in expanded traces (Bi and Bii), gray arrows at top indicate unilateral injections for SalinepFL. Bi) Rest. Bii) Following SalinepFL. Grey vertical boxes demark phases of each breath: inspiration (I; light gray), post-inspiration (Post: medium grey), and pre-inspiration (Pre: Dark gray). a.u.: arbitrary units. C) Comparison between ventilation at rest (Rst) and after SalinepFL. Lines connect data from individual experiments, box and whisker plots show combined data. Data are normalized to highest value for that parameter, i.e., f, TI, TE, VT, GGEMG, DiaEMG, or AbdEMG regardless of whether it belonged to control or salinepFL group. Abbreviations defined in Fig 2.

https://doi.org/10.1371/journal.pone.0201485.g004

thumbnail
Fig 5. SalinepFV does not affect breathing.

A) Integrated traces from a single experiment. Black arrows at bottom indicate epochs in expanded traces (Bi and Bii), gray arrows at top indicate unilateral injections for SalinepFV. Bi) Rest. Bii) Following SalinepFV. Grey vertical boxes demark phases of each breath: inspiration (I; light gray), post-inspiration (Post: medium grey), and pre-inspiration (Pre: Dark gray). a.u.: arbitrary units. C) Comparison between ventilation at rest (Rst) and after SalinepFV. Lines connect data from individual experiments, box and whisker plots show combined data. Data are normalized to highest value for that parameter, i.e., f, TI, TE, VT, GGEMG, DiaEMG, or AbdEMG regardless of whether it belonged to control or SalinepFV group. Abbreviations defined in Fig 2.

https://doi.org/10.1371/journal.pone.0201485.g005

thumbnail
Table 2. Median and interquartile range for all recorded variables.

https://doi.org/10.1371/journal.pone.0201485.t002

Disinhibition of pFV neurons by unilateral injection of bicuculline increases VT with a reciprocal decrease in f in awake rats [21]. Furthermore, pFV appears to facilitate active expiration through projections to abdominal and genioglossus motoneurons, but does not itself induce active expiration [11]. We therefore expected that pFV disinhibition with a cocktail of bicuculline and strychnine (B+SpFV) would increase VE, as well as alter abdominal and gengioglossus activity, but would not induce active expiration. Bilateral injections of B+SpFV (n = 8) increased f, decreased TI, did not alter TE, and decreased VT and ∫DiaEMG. Bilateral B+SpFV in anesthetized rats did not alter VE due to a compensatory decrease in VT in response to an increase in f elicited by the antagonism of inhibitory receptors, which is the opposite response to unilateral injection of bicuculine in the same region in awake rats [21]. pFV disinhibition had multiple effects on genioglossus activity, increasing inspiratory-related ∫GGEMG and inducing both pre-inspiratory and post-inspiratory ∫GGEMG activity (Fig 3). In 6 out of 8 experiments, B+SpFV also induced high amplitude post-inspiratory AbdEMG activity (Fig 3A† and 3Bii†), which while rhythmic was slow, occurring every 10 ± 1 breaths. This pattern of high amplitude post-inspiratory AbdEMG activity was distinct from active expiration that occurs between every inspiration at a lower amplitude (see Fig 2 and [8, 11]. Interestingly, coincident with high amplitude post-inspiratory AbdEMG bursts, there was inhibition of GGEMG activity, showing co-ordination between GGEMG and ABDEMG during expiration (Fig 3B). In all experiments, B+SpFV also induced sighs i.e., augmented breaths with high amplitude inspiratory DiaEMG followed by prolonged TE (Fig 3A# and 3Bii#); sighs were rhythmic but slow, occurring every 12 ± 1 breaths. The high amplitude post-inspiratory AbdEMG activity was not coordinated with sighing.

To test for any nonspecific effects of pFV or pFL injections on breathing, we injected saline into both regions. In anesthetized rats, saline injections in the pFL (n = 8) did not alter f, TI, TE, VT, ∫DiaEMG, GGEMG, ∫AbdEMG, or VE (Fig 4). In anesthetized rats, saline injections in the pFV (n = 8) did not alter f, TI, TE, VT, ∫DiaEMG, ∫GGEMG, ∫AbdEMG, or VE (Fig 5).

Excitation of either pFL or pFV affects breathing pattern (Figs 68, Table 2)

Photostimulation of pFL neurons elicits active expiration [8]. We predicted that excitation of the pFL with the glutamatergic agonist AMPA (AMPApFL) would also elicit active expiration. Bilateral injections of AMPApFL (n = 8) decreased f and TI, and increased TE, VT, ∫DiaEMG, inspiratory-related ∫GGEMG activity and ∫AbdEMG (Fig 6), the latter a signature of active expiration, q.v., [8, 11]. Like B+SpFL, bilateral injections of AMPApFL did not affect Ve, presumably due to a compensatory increase in VT in response to the decrease in f.

thumbnail
Fig 6. AMPApFL induces active expiration.

A) Integrated traces from a single experiment. Black arrows at bottom indicate epochs in expanded traces (Bi and Bii), gray arrows at top indicate unilateral injections for AMPApFL. Bi) Rest. Bii) Following AMPApFL. Grey vertical boxes demark phases of each breath: inspiration (I; light gray), post-inspiration (Post: medium grey), and pre-inspiration (Pre: Dark gray). C) Comparison between ventilation at rest (Rst) and after AMPApFL injection. Lines connect data from individual experiments, box and whisker plots show combined data. Data are normalized to highest value for each parameter, i.e., f, TI, TE, VT, GGEMG, DiaEMG, or AbdEMG regardless of whether it belonged to control or AMPApFL group. *: p < 0.05. Abbreviations defined in Fig 2.

https://doi.org/10.1371/journal.pone.0201485.g006

thumbnail
Fig 7. AMPApFV increases f and VT, but does not induce post-inspiratory activity in either abdominal muscles or in pre- and post-inspiratory activity gengioglossus muscles.

A) Integrated traces from a single experiment. Black arrows at bottom indicate epochs in expanded traces (Bi and Bii), gray arrows at top indicate unilateral injections for AMPApFV. Bi) Rest. Bii) Following AMPApFV. Grey vertical boxes demark phases of each breath: inspiration (I; light gray), post-inspiration (Post: medium grey), and pre-inspiration (Pre: Dark gray). C) Comparison between ventilation at rest (Rst) and after AMPApFV injection. Lines connect data from individual experiments, box and whisker plots show combined data. Data are normalized to highest value for each parameter, i.e., f, TI, TE, VT, GGEMG, DiaEMG, or AbdEMG regardless of whether it belonged to control or AMPApFV group. *: p < 0.05. Abbreviations defined in Fig 2.

https://doi.org/10.1371/journal.pone.0201485.g007

thumbnail
Fig 8. GlupFV alters, but does not induce, post-inspiratory activity in either abdominal muscles or in pre- and post-inspiratory activity in genioglossus muscles.

A) Integrated traces from a single experiment, gray arrows indicate unilateral injections for GlupFV. Ai) Vagus intact. Aii) Vagotomized. B) Comparison between ventilation at rest (Rst) and after GlupFV. Bi) Vagus intact. Bii) Vagotomized. Lines connect data from individual experiments, box and whisker plots show combined data. Data are normalized to highest value for that parameter, i.e., f, TI, TE, VT, GGEMG, DiaEMG, or AbdEMG regardless of whether it belonged to control or GlupFV group. *: p < 0.05. Abbreviations defined in Fig 2.

https://doi.org/10.1371/journal.pone.0201485.g008

Excitation of pFV neurons by injection of glutamate increases phrenic nerve discharge amplitude and induces sighing in urethane anesthetized, paralyzed, artificially ventilated, vagotomized cats [22]; photostimulation of pFV neurons leads to increased sighing and respiratory frequency in conscious rats [23]. We predicted that excitation of the pFV with AMPA (AMPApFV) would increase ventilation and sighing. Bilateral injection of AMPApFV (n = 8) increased f, decreased TI, did not alter TE, and increased VT, ∫DiaEMG, and inspiratory-related ∫GGEMG, but neither induced expiratory-modulated GGEMG nor AbdEMG (Fig 7). Unlike B+SpFV, bilateral injections of AMPApFV increased VE due to increases in both VT and f. In 5 out of 8 rats, before AMPApFV caused VT to reach maximal amplitude it induced 1–2 sigh like events, but with no associated GGEMG or AbdEMG activity (data not shown).

The lack of induction of sighing could have been due to either the increased VT in vagotomized rats, or due to the lack of activation of other glutamatergic receptors, e.g., NMDA, mGluR, etc, in addition to AMPA receptors. To explore these possibilities, in separate experiments, we injected glutamate into the pFV (GlupFV) of anesthetized rats before and after vagotomy. Before vagotomy (n = 8), bilateral GlupFV decreased f, increased TI, TE, VT, ∫DiaEMG, inspiratory-related ∫GGEMG (Fig 8), and sigh rate, but neither induced expiratory-modulated GGEMG nor AbdEMG (Fig 8). Bilateral injections of GlupFV did not affect VE due to a compensatory decrease in f in response to an increase in VT, elicited by the activation of glutamate receptors. Following vagotomy, bilateral GlupFV increased f, decreased TI, did not alter TE, and increased VT, ∫DiaEMG, and inspiratory-related ∫GGEMG, but neither induced expiratory-modulated GGEMG nor AbdEMG (Fig 8), similar to AMPApFV (Fig 7). Like AMPApFV, bilateral injections of GlupFV increased VE due to increases in both VT and f. In 3 out of 6 vagotomized rats, before GlupFV caused VT to reach maximal amplitude it induced 3–6 sigh-like events but with no associated GGEMG or AbdEMG (data not shown).

Reduced excitation of pFV and pFL have different effects on breathing (Figs 9 and 10, Table 2)

Many, if not most or all, pFL neurons are silent at rest [8, 24]; not surprisingly, hyperpolarizing pFL neurons at rest does not affect ventilation [11]. We predicted that reduction of pFL excitability with local injection of a cocktail of the glutamatergic antagonists AP-5 and NBQX (A+NpFL) would not affect breathing. Bilateral injections of A+NpFL (n = 8) had no effect on f, TI, TE, VT, ∫DiaEMG, or ∫GGEMG; AbdEMG silent at rest, remained so after A+NpFL (Fig 9). Bilateral injections of A+NpFL did not affect VE as it neither affected VT nor f.

thumbnail
Fig 9. A+NpFL does not affect breathing.

A) Integrated traces from a single experiment. Black arrows at bottom indicate epochs in expanded traces (Bi and Bii), gray arrows at top indicate unilateral injections for A+NpFL. Bi) Rest. Bii) Following A+NpFL. Grey vertical boxes demark phases of each breath: inspiration (I; light gray), post-inspiration (Post: medium grey), and pre-inspiration (Pre: Dark gray). C) Comparison between ventilation at rest (Rst) and after A+NpFL injection. Lines connect data from individual experiments, box and whisker plots show combined data. Data are normalized to highest value for each parameter, i.e., f, TI, TE, VT, GGEMG, DiaEMG, or AbdEMG regardless of whether it belonged to control or A+NpFL group. Abbreviations defined in Fig 2.

https://doi.org/10.1371/journal.pone.0201485.g009

thumbnail
Fig 10. A+NpFV decreases VT, and reduces output of inspiratory muscles.

A) Integrated traces from a single experiment. Black arrows at bottom indicate epochs in expanded traces (Bi and Bii), gray arrows at top indicate unilateral injections for A+NpFV. Bi) Rest. Bii) Following A+NpFV. Grey vertical boxes demark phases of each breath: inspiration (I; light gray), post-inspiration (Post: medium grey), and pre-inspiration (Pre: Dark gray). C) Comparison between ventilation at rest (Rst) and after A+NpFV injection. Lines connect data from individual experiments, box and whisker plots show combined data. Data are normalized to highest value for each parameter, i.e., f, TI, TE, VT, GGEMG, DiaEMG, or AbdEMG regardless of whether it belonged to control or A+NpFV group. *: p < 0.05. Abbreviations defined in Fig 2.

https://doi.org/10.1371/journal.pone.0201485.g010

By contrast, pFV neurons are active at rest, providing excitatory drive for quiet breathing [2529]; hyperpolarizing pFV neurons reduces ventilation [5, 11, 13]. We predicted that reduction of pFV excitability with local injection of AP-5 and NBQX (A+NpFV), would reduce ventilation. Bilateral A+NpFV (n = 8) increased f, decreased TI and TE, VT, ∫DiaEMG, and ∫GGEMG; AbdEMG, silent at rest, remained so after A+NpFV (Fig 10). Bilateral injections of A+NpFV did not affect VE due to a compensatory increase in f in response to a decrease in VT, elicited by the activation of glutamate receptors. That no injection into the pFV induced active expiration is indicative that the injectate did not spread to the adjacent pFL, likewise since A+NpFL did not induce any changes in breathing, this indicates the injectate did not spread to the adjacent pFV.

Discussion

Since the putative identification of a conditional expiratory oscillator in the rostral medulla [10, 12, 30], attention has focused on regions surrounding the facial nucleus as its location [8, 11, 15, 24, 31]. We identified two functionally separate parafacial regions: the pFV and pFL [11]. We propose that the pFV provides a critical generic drive to breathe, driving inspiration at rest and facilitating both inspiration and expiration when chemosensory drive increases [11, 15], and that the pFL is silent at rest, but once activated, drives active expiration [8, 11]. Additionally, there appears to be a third parafacial region, more dorsocaudal, containing neurons expressing gastrin releasing peptide that modulates baseline sigh rate [16]. Thus, there appear to be several distinct parafacial regions contributing to the bCPG. To further investigate the role of parafacial neurons, and the neuronal composition of parafacial regions at the ventral medullary surface, we pharmacologically altered the excitability of pFV and pFL neurons and measured the effects on breathing.

Further support of the hypothesis of the pFL as the source for active expiration

Antagonizing ionotropic glutamate receptors with A+NpFL did not alter any respiratory parameter, i.e., no change in f, TI, TE, VT, DiaEMG, GGEMG, or AbdEMG, supporting our previous observation that these neurons are silent at rest, q.v., [8, 11]. In the pFL, excitation (with AMPA) or disinhibition (by antagonizing ionotropic GABA and glycine receptors with B+S) decreased f with a compensatory increase in VT and inspiratory DiaEMG and GGEMG, and onset of expiratory bursting on GGEMG and AbdEMG, i.e., active expiration [8, 11]. Thus, these excitatory neurons have presumptive projections to neurons in the preBötzinger Complex (preBötC) or Bötzinger Complex (BötC) [32, 33] that inhibit inspiration during expiration, i.e., reciprocal inhibition, and to excitatory premotoneurons in the caudal ventral respiratory group (cVRG) that project to abdominal muscle motoneurons [3436]. Given the delayed increase in VT following the induced decrease in f, a direct excitatory projection from the pFL to the preBötC appears unlikely, but rather suggests an indirect pathway related to controlling pCO2, perhaps via the pFV. These observations are consistent with our hypothesis that the pFL is a conditional expiratory oscillator with neurons that are tonically inhibited at rest that can be turned on either by disinhibition and/or excitation.

Multifunctional role of the pFV

A+NpFV injected into the pFV to lower its excitability, decreased VT and inspiratory-related muscle activity, likely via projections to the preBötC and/or the rostral ventral respiratory group (rVRG) [37]. The associated delayed increase in f could again be explained as intrinsic to the slower time course of chemosensory feedback to maintain pCO2. As no change in phase durations or f were seen, it appears unlikely that this excitatory drive to inspiration was mediated by rhythmic preBӧtC neurons [38]. Rather, this observation is consistent with our hypothesis of a subpopulation of tonically active pFV neurons that provides facilitative drive to phrenic and/or other inspiratory pump motoneurons to affect VT, but do not contribute directly to regulating f or inspiratory drive to genioglossal motoneurons [11]. Instead it is more likely that the pFV affects VT through its projections to the rVRG [39], the premotor bulbospinal relay to the phrenic nucleus for inspiratory drive [40], as this will alter VT without directly altering other inspiratory parameters, i.e., f and GGEMG.

B+SpFV to increase pFV excitability, increased f, most likely through projections to the preBӧtC [38, 41], presumably to the same neurons that lead to an increase in f following optogenetic photostimulation of the pFV [42, 43]. B+SpFV also increased inspiratory-related GGEMG, likely through pFV projections to the parahypoglossal region (pXII) [39], which appears to be the premotor relay for inspiratory drive to the XII nucleus [44]. Though B+SpFV attenuated DiaEMG and VT, this appeared secondary to the reduction in f and thus was most likely due to chemosensory feedback to control pCO2. This further supports our hypothesis of a subpopulation of tonically suppressed pFV neurons that provide facilitative drive to modulate f, but does not contribute directly to VT.

Unlike B+SpFV, AMPApFV potentiated VT and DiaEMG activity, most likely through excitation of the neurons that were attenuated by A+NpFV and project to the rVRG. AMPApFV also increased f and inspiratory-related GGEMG most likely through excitation of neurons that project to the preBӧtC and parahypoglossal region that were activated following B+SpFV. As B+SpFV and AMPApFV each led to different patterns of breathing with neither similar to the effects of activating the pFL, we suggest that there are at least two relevant pFV subpopulations, one expressing inhibitory receptors and one that does not, and that both of these subgroups are distinct from the pFL.

Similar to stimulation of pFV neurons in awake behaving vagus intact rats [23] and in vagotomized urethane anesthetized cats [22], disinhibition with B+SpFV elicited sighs in vagotomized rats (Fig 3Bii#), as did excitation with GlupFV in vagus-intact rats (Fig 8A). In vagotomized rats the amplitude of normal breaths is considerably larger than vagus-intact rats, with the consequence that sighs are masked. Accordingly, when VT was low, i.e., in vagus-intact rats or following a reduction in amplitude caused by B+SpFV in vagotomized rats, sustained increases in sigh activity could be seen. This confirms our recent study showing a cluster of neurons in the pFV that release bombesin-like neuropeptides that affect sighing through the activation of cognate receptors in the preBötC [16].

Hyperpolarizing pFV neurons during hypercapnia and hypoxia affects the amplitude of AbdEMG and GGEMG, but not VT or f [11], likely through direct projections to the cVRG [15] and parahypoglossal region [39]. Interestingly, B+SpFV induced high amplitude post-inspiratory activity on both GGEMG and AbdEMG, likely through the same projections, supporting our previous finding that the pFV provides excitatory drive to expiratory premotor nuclei independent of its projections to the preBӧtC [11]. Interestingly, no perturbation of pFV excitability induced active expiration, while hyperpolarization of the pFV reduces active expiration during chemosensory stimulation [11, 13]. We conclude that the pFV provides can modulate expiratory activity generated elsewhere, but cannot itself induce active expiration.

Interestingly, most manipulations which changed either f or VT led to compensatory changes, presumably to regulate VE to control pCO2 to within the normal range. For example, reducing excitation in the pFV reduced activity of neurons that influence diaphragmatic (pre)motoneurons, which are constitutively active at rest. Thus, this manipulation reduced VT, but had no effect on f as the pFV neurons that influence f were supressed at rest and therefore their activity could not be affected by A+N; this allows for other brain regions to affect preBötC rhythmogenic neurons to increase f to compensate for the reduction in VT. Only one manipulation, glutamatergic activation of the pFV (with either AMPA or Glu) changed VE. We believe that this is because glutamatergic activation of the pFV RTN leads to activation of the tonically supressed neurons that activate preBötC rhythmogenic neurons; furthermore this manipulation also excites the neurons that are active at rest that influence diaphragmatic (pre)motoneurons, consequently altering both f and VT simultaneously.

Summary

We propose that there are at least 6 subpopulations of parafacial neurons (Fig 11). The pFL is a conditional expiratory oscillator, with a functionally homogeneous population of neurons that drive active expiration (Fig 11). By contrast, the pFV provides a critical generic facilitatory drive to breathe, and consists of at least 4 functionally distinct subpopulations of neurons: i) a tonically active subpopulation that drives VT via the diaphragm; ii) one subpopulation of tonically suppressed neurons that modulate f; and; iii) a second subpopulation of tonically suppressed neurons that provide drive to abdominal and genioglossus expiratory motor pools, iv) a subpopulation of bombesin-peptide, i.e., NMB, neurons of the hypothesized peptidergic sigh circuit [16]. In addition, there is a 6th subpopulation bombesin-peptide, i.e., GRP, neurons in the dorsocaudal parafacial (pFDC) that also can modulate basal sigh rate [16].

thumbnail
Fig 11. Schematic of minimal bCPG, which consists of 4 essential components.

1) preBötzinger Complex (preBötC) drives inspiration by exciting inspiratory premotor neuronal populations projecting to inspiratory muscles, e.g., diaphragm and tongue, and inhibits pFL; 2) parafacial Dorsocaudal (pFDC) contains GRP positive neurons contributing to basal sigh rhythm. 3) pFL drives active expiration by exciting expiratory premotor neuronal populations projecting to expiratory muscles, e.g., abdominals and tongue, and excites neurons that inhibit preBötC, either in preBötC or in BötC (not shown); 4) pFV contains neurons and glia that contribute to CO2/pH regulation and integrates sensory afferents affecting breathing, including basal sigh rate, via excitatory connections to preBötC and breathing premotor and motor neurons. pFV contains 4 subpopulations: i) tonically active neurons that modulate VT and diaphragm bursting at rest; ii) tonically suppressed neurons that modulate f; iii) NMB positive neurons that affect basal sigh rate, and; iv) tonically suppressed neurons that provide rhythmic drive to abdominal and genioglossus expiratory motor pools producing active expiration.

https://doi.org/10.1371/journal.pone.0201485.g011

References

  1. 1. Champagnat J, Fortin G. Primordial respiratory-like rhythm generation in the vertebrate embryo. Trends Neurosci. 1997;20(3):119–24. http://dx.doi.org/10.1016/S0166-2236(96)10078-3. pmid:9061866
  2. 2. Champagnat J, Thoby-Brisson M, Fortin G. Chapter 3—Genetic factors determining the functional organization of neural circuits controlling rhythmic movements: the murine embryonic parafacial rhythm generator. Prog Brain Res. 2010;187:39–46. pmid:21111199
  3. 3. Mulkey DK, Stornetta RL, Weston MC, Simmons JR, Parker A, Bayliss DA, et al. Respiratory control by ventral surface chemoreceptor neurons in rats. Nat Neurosci. 2004;7(12):1360–9. pmid:15558061
  4. 4. Ramanantsoa N, Hirsch MR, Thoby-Brisson M, Dubreuil V, Bouvier J, Ruffault PL, et al. Breathing without CO2 chemosensitivity in conditional Phox2b mutants. J Neurosci. 2011;31(36):12880–8. Epub 2011/09/09. pmid:21900566.
  5. 5. Nattie EE, Li A. Substance P-saporin lesions of neurons with NK1 receptors in one chemosensitive site in rats decreases ventillation and chemosensitivity. J Physiol. 2002;544(2):603–16.
  6. 6. Onimaru H, Ikeda K, Kawakami K. CO2-sensitive preinspiratory neurons of the parafacial respiratory group express Phox2b in the neonatal rat. J Neurosci. 2008;28(48):12845–50. pmid:19036978
  7. 7. Onimaru H, Homma I. A novel functional neuron group for respiratory rhythm generation in the ventral medulla. J Neurosci. 2003;23(4):1478–86. pmid:12598636
  8. 8. Pagliardini S, Janczewski WA, Tan W, Dickson CT, Deisseroth K, Feldman JL. Active expiration induced by excitation of ventral medulla in adult anesthetized rats. J Neurosci. 2011;31(8):2895–905. pmid:21414911
  9. 9. Oku Y, Masumiya H, Okada Y. Postnatal developmental changes in activation profiles of the respiratory neuronal network in the rat ventral medulla. J Physiol. 2007;585(1):175–86.
  10. 10. Mellen NM, Janczewski WA, Bocchiaro CM, Feldman JL. Opioid-induced quantal slowing reveals dual networks for respiratory rhythm generation. Neuron. 2003;37(5):821–6. pmid:12628172.
  11. 11. Huckstepp RTR, Cardoza KP, Henderson LE, Feldman JL. Role of parafacial nuclei in control of breathing in adult rats. J Neurosci. 2015;35:1052–67. pmid:25609622
  12. 12. Janczewski WA, Feldman JL. Distinct rhythm generators for inspiration and expiration in the juvenile rat. J Physiol. 2006;570(2):407–20.
  13. 13. Marina N, Abdala AP, Trapp S, Li A, Nattie EE, Hewinson J, et al. Essential role of Phox2b-expressing ventrolateral brainstem neurons in the chemosensory control of inspiration and expiration. J Neurosci. 2010;30(37):12466–73. Epub 2010/09/17. pmid:20844141; PubMed Central PMCID: PMC3026590.
  14. 14. Abbott SBG, Stornetta RL, Coates MB, Guyenet PG. Phox2b-expressing neurons of the parafacial region regulate breathing rate, inspiration, and expiration in conscious rats. J Neurosci. 2011;31(45):16410–22. pmid:22072691
  15. 15. Silva JN, Tanabe FM, Moreira TS, Takakura AC. Neuroanatomical and physiological evidence that the retrotrapezoid nucleus/parafacial region regulates expiration in adult rats. Respir Physiol Neurobiol. 2016;227:9–22. pmid:26900003
  16. 16. Li P, Janczewski WA, Yackle K, Kam K, Pagliardini S, Krasnow MA, et al. The peptidergic control circuit for sighing. Nature. 2016;530(7590):293–7. http://www.nature.com/nature/journal/v530/n7590/abs/nature16964.html#supplementary-information. pmid:26855425
  17. 17. Swanson LW, Sawchenko PE. Paraventricular Nucleus:A Site for the Integration of Neuroendocrine and Autonomic Mechanisms. Neuroendocrinology. 1980;31(6):410–7. pmid:6109264
  18. 18. Loewy AD, Burton H. Nuclei of the solitary tract: Efferent projections to the lower brain stem and spinal cord of the cat. J Comp Neurol. 1978;181(2):421–49. pmid:690272
  19. 19. Bandler R, Shipley MT. Columnar organization in the midbrain periaqueductal gray: modules for emotional expression? Trends Neurosci. 1994;17(9):379–89. https://doi.org/10.1016/0166-2236(94)90047-7. pmid:7817403
  20. 20. Faul F, Erdfelder E, Lang A-G, Buchner A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods. 2007;39(2):175–91. pmid:17695343
  21. 21. Nattie EE, Shi J, Li A. Bicuculline dialysis in the retrotrapezoid nucleus (RTN) region stimulates breathing in the awake rat. Respir Physiol 2001;124(3):179–93. http://dx.doi.org/10.1016/S0034-5687(00)00212-7. pmid:11173073
  22. 22. Nattie EE, Li A. Retrotrapezoid nucleus glutamate injections: long-term stimulation of phrenic activity. J Appl Physiol. 1994;76(2):760–72. pmid:7909799
  23. 23. Abbott SBG, Coates MB, Stornetta RL, Guyenet PG. Optogenetic stimulation of C1 and retrotrapezoid nucleus neurons causes sleep state–dependent cardiorespiratory stimulation and arousal in rats. Hypertension. 2013;61(4):835–41. pmid:23438930
  24. 24. de Britto AA, Moraes DJA. Non-chemosensitive parafacial neurons simultaneously regulate active expiration and airway patency under hypercapnia in rats. J Physiol. 2017;595(6):2043–64. pmid:28004411
  25. 25. Nattie EE. Multiple sites for central chemoreception: their role in response sensitivity and in sleep and wakefullness. Resp Physiol. 2000;122:223–35.
  26. 26. Mulkey DK, Rosin DL, West G, Takakura AC, Moreira TS, Bayliss DA, et al. Serotonergic neurons activate chemosensitive retrotrapezoid nucleus neurons by a pH-independent mechanism. J Neurosci. 2007;27(51):14128–38. pmid:18094252
  27. 27. Li A, Zhou S, Nattie EE. Simultaneous inhibition of caudal medullary raphe and retrotrapezoid nucleus decreases breathing and the CO2 response in conscious rats. J Physiol. 2006;577(1):307–18.
  28. 28. Nattie EE, Li A. CO2 dialysis in nucleus tractus solitarius region of rat increases ventilation in sleep and wakefulness. J Appl Physiol. 2002;92:2119–30. pmid:11960965
  29. 29. Moreira TS, Takakura AC, Colombari E, Guyenet PG. Activation of 5-hydroxytryptamine type 3 receptor-expressing C-fiber vagal afferents inhibits retrotrapezoid nucleus chemoreceptors in rats. J Neurophysiol. 2007;98(6):3627–37. pmid:17928558
  30. 30. Janczewski WA, Feldman JL. Novel data supporting the two respiratory rhythm oscillator hypothesis. focus on "respiration-related rhythmic activity in the rostral medulla of newborn rats". J Neurophysiol. 2006;96:1–2. pmid:16554514
  31. 31. Huckstepp RTR, Henderson LE, Cardoza KP, Feldman JL. Interactions between respiratory oscillators in adult rats. eLife. 2016;5:e14203. pmid:27300271
  32. 32. Morgado-Valle C, Baca SM, Feldman JL. Glycinergic pacemaker neurons in preBötzinger Complex of neonatal mouse. J Neurosci. 2010;30(10):3634–9. pmid:20219997
  33. 33. Schreihofer AM, Stornetta RL, Guyenet PG. Evidence for glycinergic respiratory neurons: Bötzinger neurons express mRNA for glycinergic transporter 2. J Comp Neurol. 1999;407(4):583–97. pmid:10235646
  34. 34. Iscoe S. Control of abdominal muscles. Prog Neurobiol. 1998;56(4):433–506. pmid:9775401
  35. 35. Cinelli E, Bongianni F, Pantaleo T, Mutolo D. Modulation of the cough reflex by GABAA receptors in the caudal ventral respiratory group of the rabbit. Front Physiol. 2012;3:403. pmid:23087651
  36. 36. Janczewski WA, Onimaru H, Homma I, Feldman JL. Opioid-resistant respiratory pathway from the preinspiratory neurones to abdominal muscles: in vivo and in vitro study in the newborn rat. J Physiol. 2002;545(3):1017–26. pmid:12482904
  37. 37. Núñez-Abades PA, Morillo AM, Pásaro R. Brainstem connections of the rat ventral respiratory subgroups: afferent projections. J Auton Nerv Syst. 1993;42(2):99–118. pmid:8383713
  38. 38. Cui Y, Kam K, Sherman D, Janczewski WA, Zheng Y, Feldman JL. Defining preBötzinger Complex rhythm- and pattern-generating neural microcircuits in vivo. Neuron. 2016;91(3):602–14. pmid:27497222
  39. 39. Rosin DL, Chang DA, Guyenet PG. Afferent and efferent connections of the rat retrotrapezoid nucleus. J Comp Neurol. 2006;499(1):64–89. Epub 2006/09/08. pmid:16958085.
  40. 40. Portillo F, Nunez-Abades A. Distribution of bulbospinal neurones supplying bilateral innervation to the phrenic nucleus in the rat. Brain Res. 1992;583:349–55. pmid:1380401
  41. 41. Smith JC, Morrison DE, Ellenberger HH, Otto MR, Feldman JL. Brainstem projections to the major respiratory neuron populations in the medulla of the cat. J Comp Neurol. 1989;281(1):69–96. pmid:2466879.
  42. 42. Abbott SBG, Stornetta RL, Socolovsky CS, West GH, Guyenet PG. Photostimulation of channelrhodopsin-2 expressing ventrolateral medullary neurons increases sympathetic nerve activity and blood pressure in rats. J Physiol. 2009;587(23):5613–31. pmid:19822543
  43. 43. Burke PGR, Kanbar R, Viar KE, Stornetta RL, Guyenet PG. Selective optogenetic stimulation of the retrotrapezoid nucleus in sleeping rats activates breathing without changing blood pressure or causing arousal or sighs. J Appl Physiol. 2015;118(12):1491–501. PubMed PMID: PMC4469924. pmid:25858492
  44. 44. Chamberlin NL, Eikermann M, Fassbender P, White DP, Malhotra A. Genioglossus premotoneurons and the negative pressure reflex in rats. J Physiol. 2007;579(2):515–26. pmid:17185342